Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer. Shiozawa T, Numata T, Tamura T, Endo T, et al. Anticancer Res 2022;42:2583-2590.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shiozawa T, Numata T, Tamura T, Endo T, et al. Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer. Anticancer Res 2022;42:2583-2590.
PMID: 35489768